Common Contracts
1 similar null contracts
FINAL PROJECT AGREEMENT SIGNED SEPTEMBER 22, 2000September 30th, 2014
The Project Sponsor: Ortho-McNeil Pharmaceu tical (OMP) and the R.W. Johnson Pharmaceuti cal Research Institute (PRI), divisions of Johnson & Johnson, are jointly sponsoring this XL project. OMP manufactures and markets pharmaceutical products in several therapeutic categories, includ ing women’s health, central nervous system, in fectious disease, and wound healing. OMP’s research and development efforts are conducted by PRI, a sister company. PRI develops and uses radiolabeled compounds for the research and de velopment of pharmaceuticals/drugs. OMP is headquartered in Raritan, New Jersey, and employs more than 2,000 people. The company has manu facturing operations in Raritan, New Jersey; Spring House, Pennsylvania; and Manati and Dorado, Puerto Rico. This project is being conducted at the Spring House, Pennsylvania, site.
